NCT05618041 The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies Status RECRUITING Phase NA
NCT05589896 A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies Status RECRUITING Phase PHASE1/PHASE2
NCT05587582 Behavioral Parenting Skills As A Novel Target for Improving Pediatric Medication Adherence Status COMPLETED Phase N/A
NCT05581030 CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) Status RECRUITING Phase PHASE1
NCT05579132 A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic Leukemia (MK-1045-002) Status RECRUITING Phase PHASE1/PHASE2
NCT05578378 Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in R/R ALL Status UNKNOWN Phase PHASE2/PHASE3
NCT05563545 Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE1
NCT05541341 Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies Status RECRUITING Phase N/A
NCT05535855 UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1 Status RECRUITING Phase PHASE1
NCT05521087 A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias Status WITHDRAWN Phase PHASE1
NCT05519579 Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE2
NCT05515029 Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05501899 Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia Status RECRUITING Phase EARLY_PHASE1
NCT05457556 Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05442515 CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies Status RECRUITING Phase PHASE1/PHASE2
NCT05433532 Study of Azacitidine,Venetoclax,and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients Status COMPLETED Phase PHASE2
NCT05428176 A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors Status ACTIVE_NOT_RECRUITING Phase NA
NCT05410574 Family-Based Behavioral Treatment for Childhood Survivors of Acute Lymphoblastic Leukemia Status TERMINATED Phase NA
NCT05400122 Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer Status SUSPENDED Phase PHASE1
NCT05386576 A Study of Venetoclax in Combination With Chemotherapy to Treat Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1